Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to $164802.0.

  • cbdMD's Capital Expenditures rose 25.25% to $164802.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $184587.0, marking a year-over-year increase of 872.96%. This contributed to the annual value of $184172.0 for FY2025, which is 307.5% down from last year.
  • Per cbdMD's latest filing, its Capital Expenditures stood at $164802.0 for Q4 2025, which was up 25.25% from $2804.0 recorded in Q3 2025.
  • In the past 5 years, cbdMD's Capital Expenditures registered a high of $231030.0 during Q4 2021, and its lowest value of -$102390.0 during Q1 2023.
  • In the last 5 years, cbdMD's Capital Expenditures had a median value of $102389.0 in 2023 and averaged $93365.1.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 64392.76% in 2022, then plummeted by 17171.93% in 2023.
  • Over the past 5 years, cbdMD's Capital Expenditures (Quarter) stood at $231030.0 in 2021, then dropped by 23.23% to $177370.0 in 2022, then increased by 4.1% to $184635.0 in 2023, then dropped by 10.97% to $164387.0 in 2024, then grew by 0.25% to $164802.0 in 2025.
  • Its last three reported values are $164802.0 in Q4 2025, $2804.0 for Q3 2025, and $1475.0 during Q2 2025.